Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

BW Dunlop, T Li, SG Kornstein, ES Friedman… - Journal of psychiatric …, 2011 - Elsevier
We conducted a secondary analysis of data from the Prevention of Recurrent Episodes of
Depression With Venlafaxine Extended Release (ER) for Two Years (PREVENT) trial to …
被引用次数：49 相关文章

Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

BW Dunlop, T Li, SG Kornstein… - Journal of …, 2011 - utsouthwestern.elsevierpure.com
We conducted a secondary analysis of data from the Prevention of Recurrent Episodes of
Depression With Venlafaxine Extended Release (ER) for Two Years (PREVENT) trial to …

Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

BW Dunlop, T Li, SG Kornstein, ES Friedman… - Journal of Psychiatric …, 2011 - infona.pl
We conducted a secondary analysis of data from the Prevention of Recurrent Episodes of
Depression With Venlafaxine Extended Release (ER) for Two Years (PREVENT) trial to …

Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

BW Dunlop, T Li, SG Kornstein, ES Friedman… - 2011 - repository.escholarship.umassmed …
We conducted a secondary analysis of data from the Prevention of Recurrent Episodes of
Depression With Venlafaxine Extended Release (ER) for Two Years (PREVENT) trial to …
[PDF] academia.edu

[PDF][PDF] Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

BW Dunlopa, T Lib, SG Kornsteind, ES Friedmane… - J Psychiatr …, 2011 - academia.edu
We conducted a secondary analysis of data from the Prevention of Recurrent Episodes of
Depression With Venlafaxine Extended Release (ER) for Two Years (PREVENT) trial to …

[引用][C] Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

BW Dunlop, T Li, SG Kornstein, ES Friedman… - Journal of Psychiatric …, 2011 - cir.nii.ac.jp
Concordance between clinician and patient ratings as predictors of response, remission,
and recurrence in major depressive disorder | CiNii Research CiNii 国立情報学研究所 学術 …

Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder.

BW Dunlop, T Li, SG Kornstein… - Journal of Psychiatric …, 2010 - europepmc.org
We conducted a secondary analysis of data from the P revention of R ecurrent E pisodes of
Depression With Ven lafaxine Extended Release (ER) for T wo Years (PREVENT) trial to …

Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

BW Dunlop, T Li, SG Kornstein… - Journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
We conducted a secondary analysis of data from the Prevention of Recurrent Episodes of
Depression With Venlafaxine Extended Release (ER) for Two Years (PREVENT) trial to …

[引用][C] Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

BW DUNLOP, T LI, SG KORNSTEIN… - Journal of …, 2011 - pascal-francis.inist.fr
Concordance between clinician and patient ratings as predictors of response, remission,
and recurrence in major depressive disorder CNRS Inist Pascal-Francis CNRS Pascal and …
[HTML] nih.gov

[HTML][HTML] Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder

BW Dunlop, T Li, SG Kornstein… - Journal of psychiatric …, 2011 - ncbi.nlm.nih.gov
We conducted a secondary analysis of data from the P revention of R ecurrent E pisodes of
Depression With Ven lafaxine Extended Release (ER) for T wo Years (PREVENT) trial to …